Latest news articles

Added 16 days ago Drug news

Genentech’s Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer.

Genentech, announced positive data from the Phase III IMpower110 study evaluating Tecentriq (atezolizumab) as a first-line (initial) monotherapy compared with...

Added 19 days ago Drug news

Final results from CheckMate -227 part 1 demonstrating superior overall survival for Opdivo + low-dose Yervoy vs. Chemotherapy in advanced non-small cell lung cancer.- BMS

Bristol-Myers Squibb Company announced results from Part 1 of the Phase III CheckMate -227 trial evaluating Opdivo (nivolumab) plus low-dose...

Added 1 month ago Drug news

Phase III IMpower110 study of Tecentriq monotherapy meets endpoint in NSCLC

Genentech/Roche announced positive data from the Phase III IMpower110 study evaluating Tecentriq (atezolizumab) as a first-line (initial) monotherapy compared with...

Search all news articles for Cancer of bronchus or lung
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

Load more

Guidelines

Lung cancer: diagnosis and management

This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to...

Added 8 years ago

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship.

Added 6 years ago

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest prevalence in lung cancer. Dyspnoea has been demonstrated to be one of the most distressing...

Added 4 years ago

Search all guidelines for Cancer of bronchus or lung
 

Journal articles

Dendritic Cells in Human Lung Disease: Recent Advances.

Dendritic cells (DCs) are potent antigen-presenting cells. Because of their particular ability to initiate and regulate cell mediated and humoral immune responses, there is considerable interest in the role that DCs play in the pathogenesis...

Added 23 days ago

Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC.

Introduction: Durvalumab is a selective, high-affinity human IgG1 monoclonal antibody that blocks programmed cell death ligand-1 (PD-L1) binding to PD-1. Here we report safety and clinical activity in the non-small cell...

Added 29 days ago

Current status of immune checkpoint inhibition in early stage NSCLC.

Immune checkpoint inhibition (ICI) immunotherapy has revolutionized the approach to metastatic non-small-cell lung cancer (NSCLC). In particular, antibodies blocking the inhibitory immune checkpoints programmed death...

Added 1 month ago

Search all journal articles for Cancer of bronchus or lung
 

Clinical trials

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

The incidence rate of ground-glass opacity (GGO) has been increasing these years. A great number of retrospective studies suggested that sublobar resection was better for some GGO patients.

Added 1 year ago

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy (OAK)

This global, multicenter, open-label, randomized, controlled study will evaluate the efficacy and safety of atezolizumab (an anti-programmed death−ligand 1 [anti-PD-L1] antibody) compared with docetaxel...

Added 2 years ago

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer (OREX-IA)

The purpose of this study is to determine the outcome of participants with clinical stage IA NSCLC treated by 3 types of surgical resection (wide wedge resection, segmentectomy, or lobectomy) according to the institutional decision-making algorithm

Added 1 year ago

Search all clinical trials for Cancer of bronchus or lung
 
Advances in Precision Cancer Care

Advances in Precision Cancer Care aims to bring you the latest news and some of the most exciting developments in precision cancer care.

Our first reports come from ESMO Congress 2018.

ESMO 2018 | Day 1 highlights

Today’s report come from the Proffered paper session - NSCLC, metastatic, focusing on presentations LBA50 and LBA51 discussing mechanisms of acquired resistance to osimertinib from the phase III trials FLAURA and AURA3, respectively.

CME

Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Non-small cell lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Cancer of bronchus or lung